Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis, and chronic cough... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| KGGIX | 14.40 | -0.15 | -1.03% |
| Kopernik Global All-Cap I | |||
| HDGSX | 35.15 | -0.41 | -1.15% |
| Hartford Dividend and Growth R4 | |||
| BIRKX | 21.63 | -0.26 | -1.19% |
| BlackRock Sustainable Adg Lg Cp Cr K | |||
| TLCIX | 19.45 | -0.28 | -1.42% |
| Touchstone Large Cap Institutional | |||
| WESCX | 20.61 | -0.43 | -2.04% |
| TETON Westwood SmallCap Equity AAA | |||
A.I.dvisor tells us that AGNPF and CYDY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGNPF and CYDY's prices will move in lockstep.
| Ticker / NAME | Correlation To AGNPF | 1D Price Change % | ||
|---|---|---|---|---|
| AGNPF | 100% | -8.68% | ||
| CYDY - AGNPF | 24% Poorly correlated | -0.59% | ||
| WVE - AGNPF | 23% Poorly correlated | -3.47% | ||
| PHIO - AGNPF | 21% Poorly correlated | -8.10% | ||
| IBIO - AGNPF | 20% Poorly correlated | -9.89% | ||
| ABCZF - AGNPF | 12% Poorly correlated | N/A | ||
More | ||||